PD Dr. med. Matthias Dollinger
1 clinical trials · Sponsor
◉ Watch PD Dr. med. Matthias Dollinger
| Record | Firm | Date |
|---|---|---|
| Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial (NCT01272557) | PD Dr. med. Matthias Dollinger | 2010-12-01 |
Track PD Dr. med. Matthias Dollinger automatically
Every clearance here is in the API, with alerts when new ones post.